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I N T R O D U C T I O N
All neural function results from a series of electrical and 
chemical signals. The two realms of signaling are often 
bridged within neurons by voltage-gated Ca
2+ channels, 
such as N channels (West et al., 2001). With depolariza-
tion of postsynaptic sites, N-channel activity (N current) 
triggers  biochemical  changes,  including  modulation   
of certain ion channels (Wisgirda and Dryer, 1994), en-
zyme activation (Rittenhouse and Zigmond, 1999), and 
gene transcription (Brosenitsch and Katz, 2001; West   
et al., 2001; Zhao et al., 2007). In turn, Gq protein-cou-
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pled receptors (PCRs) converge on several signal trans-
duction cascades to modulate the N channel’s response 
to changing membrane potential. Some of these path-
ways are well described, so both signaling molecules and 
sites of modulation on N channels are known (Suh and 
Hille, 2005).
A  notable  exception  is  the  M1  receptor  (M1R),  a 
GqPCR that modulates postsynaptic N current by an in-
completely described signaling cascade referred to as 
the  slow  pathway  (Beech  et  al.,  1992;  Mathie  et  al., 
1992). Other transmitters such as substance P (SP), the 
natural ligand for the neurokinin-1 receptor (NK-1R), 
also modulate N current by a slow pathway (Shapiro 
and Hille, 1993; Kammermeier et al., 2000) that cou-
ples to Gq (Macdonald et al., 1996), suggesting that 
multiple GqPCRs converge on this pathway (Suh and 
Hille, 2005). Recent studies propose that a reduction in   
phosphatidylinositol-4,5-bisphosphate  (PtdIns(4,5)P2) 
levels during GqPCR stimulation suffices for inhibition 
(Wu et al., 2002; Gamper et al., 2004; Michailidis et al., 
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In superior cervical ganglion (SCG) neurons, stimulation of M1 receptors (M1Rs) produces a distinct pattern of 
modulation of N-type calcium (N-) channel activity, enhancing currents elicited with negative test potentials and 
inhibiting currents elicited with positive test potentials. Exogenously applied arachidonic acid (AA) reproduces 
this profile of modulation, suggesting AA functions as a downstream messenger of M1Rs. In addition, techniques 
that diminish AA’s concentration during M1R stimulation minimize N-current modulation. However, other studies 
suggest depletion of phosphatidylinositol-4,5-bisphosphate during M1R stimulation suffices to elicit modulation. 
In this study, we used an expression system to examine the physiological mechanisms regulating modulation. 
We found the  subunit (CaV) acts as a molecular switch regulating whether modulation results in enhancement or 
inhibition. In human embryonic kidney 293 cells, stimulation of M1Rs or neurokinin-1 receptors (NK-1Rs) inhib-
ited activity of N channels formed by CaV2.2 and coexpressed with CaV1b, CaV3, or CaV4 but enhanced activity 
of N channels containing CaV2a. Exogenously applied AA produced the same pattern of modulation. Coexpres-
sion of CaV2a, CaV3, and CaV4 recapitulated the modulatory response previously seen in SCG neurons, imply-
ing heterogeneous association of CaV with CaV2.2. Further experiments with mutated, chimeric CaV subunits 
and free palmitic acid revealed that palmitoylation of CaV2a is essential for loss of inhibition. The data presented 
here fit a model in which CaV2a blocks inhibition, thus unmasking enhancement. Our discovery that the pres-
ence or absence of palmitoylated CaV2a toggles M1R- or NK-1R–mediated modulation of N current between en-
hancement and inhibition identifies a novel role for palmitoylation. Moreover, these findings predict that at 
synapses, modulation of N-channel activity by M1Rs or NK-1Rs will fluctuate between enhancement and inhibition 
based on the presence of palmitoylated CaV2a.
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y370 Cav2a toggles N-current modulation by GqPCRs
Eagle’s medium/F12 (Invitrogen) supplemented with 10% fetal 
bovine serum (Invitrogen), 1% G418 (geneticin-selective anti-
biotic, nonsterile; Invitrogen), and 1% HT supplement (Invitro-
gen). Cells were transferred into 12-well plates for transfection. 
Recombinant cells at 50–80% confluence were transfected for   
1 h with CaV2.2 e(24a, +31a, +37b), the N-channel variant found 
in SCG neurons (Lin et al., 1997); 2-1, which is also expressed 
in SCG (Lin et al., 2004); and various CaVs at a 1:1:1 or 1:1:2 
molar  ratio  along  with  enhanced  green  fluorescent  protein 
(eGFP)  at  10%  of  the  total  DNA  using  Lipofectamine  and 
PLUS reagent (Invitrogen) as per the manufacturer’s instruc-
tions. Where noted, the transfection mixture contained expres-
sion  plasmids  encoding  0.028  µg/well  NK-1R  (UMR  cDNA 
Resource Center, University of Missouri, Rolla, MO). 500–1,000 
ng total DNA was transfected per well. 24–48 h after transfection, 
cells were replated on poly-l-lysine–coated coverslips and allowed 
to settle for at least 1 h before recording. tsA 201 cells stably 
transfected  with  CaV2.2,  21,  and  CaV3  were  provided  by   
D. Lipscombe (Brown University, Providence, RI). These cells were 
transfected with 500–1,000 ng per well of the M1R (a gift from 
N. Nathanson, University of Washington, Seattle, WA) along 
with eGFP at 10% of the total DNA and processed as described 
above for current recordings.
CaV1b  (GenBank/EMBL/DDBJ  accession  no.  X61394), 
CaV2a (GenBank accession no. M80545), and CaV4 (GenBank 
accession no. L02315) were provided by E. Perez-Reyes (University 
of Virginia, Charlottesville, VA); CaV2.2 (GenBank accession no. 
AF055477), 2-1 (GenBank accession no. AF286488), and CaV3 
(GenBank accession no. M88751) were provided by D. Lipscombe. 
The CaV2a(C3,4S) mutant was provided by A. Fox (University of 
Chicago, Chicago, IL); CaV2a3 and CaV2a1b chimeras were 
provided by R. Ten Eick (Northwestern University, Evanston, IL). 
The mutant and chimeric CaVs were originally made in M. 
Hosey’s laboratory (Northwestern University; Chien et al., 1996, 
1998; Chien and Hosey, 1998). Recordings from untransfected 
HEK-M1 cells yielded whole-cell currents of 9.0 ± 1.3 pA in 20 mM 
Ba
2+ (Roberts-Crowley, M., personal communication). To avoid 
spurious results from endogenous currents, any transfected cells 
having less than 150 pA were discarded.
Preparation of neonatal rat SCG neurons for electrophysiology
Dissociated sympathetic neurons were obtained from SCG of 1–4-
d-old Sprague-Dawley rats (Charles River) according to the meth-
ods of Liu and co-workers (Liu et al., 2001; Liu and Rittenhouse, 
2003a). To isolate the actions of the slow pathway on N-type cur-
rent, cells were incubated for at least 5 h with 500 ng/ml pertussis 
toxin (Biological Laboratories, Inc.) before initiating whole-cell 
recording experiments (Bernheim et al., 1992). Also, bath solu-
tions included 1 µM of the L-type Ca
2+ channel antagonist ni-
modipine to minimize the small amount of L-type current present 
in SCG neurons. Cells were used within 12 h to avoid recording 
from cells with processes.
Electrophysiology
Ba
2+ currents were recorded at room temperature (20–24°C) 
using the whole-cell configuration of a model 3900a (Dagan), Axon 
200A, or Axon 200B (MDS Analytical Technologies) patch-clamp 
amplifier using methods that were described previously (Barrett 
et al., 2001; Liu et al., 2001). Currents were filtered at 5 kHz using 
the amplifier’s four-pole low-pass Bessel filter and were digitized 
at 20 kHz with a micro1401 interface (Cambridge Electronic   
Design [CED]). Data were collected using Patch 6.4 or Signal 
2.15 software suites (CED) and stored on a personal computer. 
Before analysis, capacitive and leak currents were subtracted 
using a scaled-up current elicited with a test pulse to 100 mV. 
Pipette resistance ranged from 2.5 to 5 M. Ba
2+ currents were 
elicited every 4 s by stepping from 90 to 0 mV for 100 ms unless 
2007). In this model, channels are available to open 
when PtdIns(4,5)P2 associates with them. During mus-
carinic stimulation, PtdIns(4,5)P2 is depleted from the 
membrane, creating a concentration gradient that fa-
vors PtdIns(4,5)P2 dissociating and diffusing away from 
channels. This model appeals to many in part because 
PtdIns(4,5)P2 dissociation and depletion have been es-
tablished as the mechanism that inhibits M current, a 
voltage-gated K
+ current (Suh and Hille, 2002, 2007; 
Ford et al., 2003; Suh et al., 2006).
However, our previous studies with superior cervical 
ganglion (SCG) neurons indicate that modulation of 
native N current by M1Rs requires events downstream of 
PtdIns(4,5)P2 hydrolysis (Liu and Rittenhouse, 2003a; 
Liu et al., 2004, 2008). We found that the muscarinic ag-
onist  oxotremorine-M  (Oxo-M)  and  arachidonic  acid 
(AA) elicit the same distinct pattern of modulation (Liu 
et al., 2001; Liu and Rittenhouse, 2003a), not only inhib-
iting N current at positive test potentials but also enhanc-
ing N current at negative test potentials (Fig. 1 A). 
Enhancement  and  inhibition  by  AA  occur  at  distinct 
sites  and  exhibit  different  biophysical  characteristics 
(Barrett et al., 2001; Liu et al., 2001). Moreover, M1R 
stimulation  releases  AA  in  central  and  SCG  neurons 
(Tencé et al., 1994; Liu et al., 2006). In contrast, only 
minimal fatty acid release occurs after muscarinic stimu-
lation in SCG neurons lacking group IVa PLA2 (Liu et 
al., 2006). Consistent with the need for PtdIns(4,5)P2 
metabolites, inhibiting AA release from phospholipids 
by antagonizing PLA2 activity or including BSA, a scaven-
ger of AA (Spector, 1975), in the bath solution minimizes 
N-current modulation by Oxo-M (Liu and Rittenhouse, 
2003a; Liu et al., 2003, 2004), suggesting that AA may be 
a second messenger of the slow pathway.
At present, no binding site for either PtdIns(4,5)P2 or 
AA  on  N  channels  has  been  determined.  Moreover, 
whether the sites that confer AA sensitivity reside in the 
same channel or whether two distinct channel popula-
tions mediate enhancement and inhibition remains 
untested. Therefore, we attempted to use the power of 
mutagenesis to separate enhancement from inhibition 
in human embryonic kidney 293 (HEK-293) cells ex-
pressing recombinant M1Rs and N channels. N channels 
are multimeric complexes defined by a large pore-
forming subunit (CaV2.2) that associates with ancillary 
2 and CaV subunits (Catterall, 2000). We made the 
serendipitous discovery that enhancement and inhibi-
tion separate without mutagenesis simply by expressing 
different wild-type CaVs.
M AT E R I A L S   A N D   M E T H O D S
Transfection of HEK-M1 cells
HEK-293 cells with a stably transfected M1R (HEK-M1; Peralta   
et al., 1988), a gift from E. Liman (University of Southern Cali-
fornia, Los Angeles, CA), were cultured in Dulbecco’s modified   Heneghan et al. 371
Figure  1.  M1R-induced  inhibition  of  recombinant  N  current 
is blocked by a PLA2 antagonist. HEK-M1 cells were transiently 
transfected with N-channel subunits CaV2.2, 2 -1, and CaV3. 
(A) Working model of the slow pathway in which AA release, 
catalyzed by PLA2, is a necessary component to elicit N-current 
modulation. AA enhances current (green arrow) by acting at a 
distinct site that may be extracellular or in the outer leaflet of the 
membrane (Barrett et al., 2001). AA inhibits N current by acting 
at an intracellular site or a site within the inner leaflet (Barrett   
et al., 2001; Liu et al., 2001). (B) Summary of the percent change 
in mean current amplitude in tsA 201 cells after 1-min exposure 
to 10 µM Oxo-M or in HEK-M1 cells in the presence or absence of 
10 µM OPC, a PLA2 antagonist. Error bars represent SEM. (C) Time 
course of peak inward current using 5 mM Ba
2+ as charge carrier   
before, during, and after bath application of 10 µM Oxo-M.   
(D) Representative whole-cell current traces selected from the re-
spective time course before (black) and 1 min after (red) Oxo-M 
application. Currents were elicited every 4 s by stepping to a test 
potential of 0 mV for 100 ms. (E and F) Modulation of N current 
from tsA 201 cells stably transfected with CaV2.2, 2-1, and CaV3 
and transiently transfected with 500–1,000 ng/well of M1Rs. eGFP 
is shown in the time course and representative sweeps. The charge 
carrier was increased to 20 mM Ba
2+ to improve the signal to noise 
ratio, and accordingly the test potential was adjusted to 10 mV.   
(G and H) HEK-M1 cells were transiently transfected with N-chan-
nel subunits CaV2.2, 2-1, and CaV2a. Modulation of N current 
by M1R stimulation illustrated in a time course (G) and current 
traces (H). (I and J) N-current modulation from cells expressing 
HEK-M1 cells transfected as for C. Cells were exposed to OPC for 
at least 3 min before application of Oxo-M. Bars, 0.4 nA.
otherwise noted. For cells expressing CaV2a, 20 mM Ba
2+ was 
used as the charge carrier to improve the signal to noise ratio. 
The internal solution contained 135 mM Cs-Asp, 10 mM HEPES, 
0.1 mM 1,2-bis(O-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid 
(BAPTA), 5 mM MgCl2, 4 mM ATP, and 0.4 mM GTP, adjusted to 
pH  7.5  with  CsOH.  The  external  solution  contained  135  mM   
N-methyl-d-glutamine-aspartate, 10 mM HEPES, and 5 or 20 mM 
Ba
2+ (as indicated), adjusted to pH 7.5 with CsOH. 135 mM N-methyl- 
d-glutamine-aspartate was substituted for Ba
2+ when its concentra-
tion was lowered from 20 to 5 mM.
Pharmacological agents
Oxo-M (Tocris Biosciences, Inc.) was prepared as a stock solution 
in double-distilled water and was diluted 1,000 times with bath so-
lution. SP was prepared as a stock solution in 0.05 M acetic acid 
and diluted at least 2,000 times with bath solution. AA (Nu-Chek 
Prep), oleyloxyethyl phosphorylcholine (OPC; EMD), and ni-
modipine were prepared as stock solutions made up in 100% eth-
anol and diluted 1,000 times with bath solution. All chemicals 
were obtained from Sigma-Aldrich except where noted.
Data analysis
The Patch 6.4 and Signal 2.15 software were used to measure 
peak inward current of whole-cell traces. A trough-seeking func-
tion was used to determine peak current where indicated. Data 
were further analyzed using Excel (Microsoft) and Origin 7.0 
(OriginLab). Percent inhibition was calculated as [(I  I’)/I] × 
100, where I is the control current amplitude determined by a 
mean of five whole-cell current measurements before applica-
tion of a particular agent and I’ is the mean of five current   
measurements at the time specified for the determination. Con-
ductance was calculated from a modified Ohm’s law equation, 
G = I/(Vm Vrev), where I is the peak current at each test potential, 
Vm is the test potential, and Vrev is the apparent reversal potential. 
Relative  conductance  curves,  (G/Gmax)    voltage  (Vm),  were 
plotted for whole-cell currents before and after AA. Data were 
curve fit using the Boltzmann equation function in Origin 7.0, 
yielding a curve fitting the equation G/Gmax = Gmax + (Gmin  
Gmax)/(1 + exp[(Vm  Vm1/2)/k)], where Gmax is the maximal 
conductance, Gmin is the minimal conductance, Vm is the test 372 Cav2a toggles N-current modulation by GqPCRs
Online supplemental material
Fig. S1 shows that exogenous application of AA inhibits N-type 
current in SCG neurons. The L-type channel agonist FPL 64176 
was used to distinguish effects of AA on N current from L cur-
rent. The AA analogue ETYA (5,8,11,14-eicosatetraynoic acid) 
was used to block metabolism of AA. Fig. S2 demonstrates that 
the  enhancing  and  inhibiting  effects  of  AA  are  reversible  us-
ing an application of fatty acid–free BSA subsequent to AA ap-
plication. Fig. S3 shows that in HEK-M1 cells transfected with 
CaV2.2, 2-1, CaV2a, and CaV3, both enhancement and in-
hibition of N current occurs during application of AA. Online 
supplemental  material  is  available  at  http://www.jgp.org/cgi/ 
content/full/jgp.200910203/DC1.
R E S U LT S
To test whether a homogeneous population of N chan-
nels  recapitulates  both  enhancement  and  inhibition,   
N currents were screened for modulation by Oxo-M. 
Recombinant currents were evoked from HEK-M1 cells 
transiently transfected with N-channel subunits CaV2.2, 
2-1, and CaV3, which most commonly associates with 
CaV2.2 (Witcher et al., 1993). Oxo-M rapidly inhibited 
peak inward current, reaching a stable inhibition within 
90 s (Fig. 1, B–D). Because N-current enhancement is 
voltage dependent (Liu and Rittenhouse, 2003a), we com-
pared current–voltage (I-V) plots measured before and 
after Oxo-M, expecting to observe current enhancement 
at negative test potentials. However, Oxo-M inhibited 
current at virtually all voltages (Fig. 2 C). tsA 201 cells 
stably transfected with the same subunits exhibited a 
similar profile of inhibition after exposure to Oxo-M (Fig. 1, 
B, E, and F), ruling out a system-specific effect.
CaV subunit controls N-current modulation by GqPCRs
Lack of enhancement at any potential indicated the 
recombinant system was fundamentally different from 
N-current modulation observed in SCG neurons. In 
addition to incomplete recapitulation of GqPCR mod-
ulation, recombinant N current exhibited robust, fast 
inactivation (Fig. 1, D and F, and Fig. 2 C) as previously 
observed  with  channels  containing  CaV3  (Olcese   
et al., 1994). In contrast, native N current in SCG neu-
rons exhibits kinetics with little inactivation (Plummer 
et al., 1989), similar to recombinant N current from 
channels containing CaV2a (Hurley et al., 2000; Yasuda 
et al., 2004). Moreover, AA robustly inhibits noninacti-
vating current in SCG neurons evoked with a test pulse 
duration ranging from 20 (Fig. S1) to 700 ms (Liu and 
Rittenhouse, 2000; Liu et al., 2001). Because SCG neu-
rons express CaV2 mRNA (Lin et al., 1996), we hy-
pothesized that the majority of N current arises from 
CaV2a-containing  channels.  If  true,  these  channels 
might exhibit both inhibition and enhancement. We 
found that Oxo-M rapidly inhibited N current from 
cells expressing CaV2a. However, unlike CaV3, initial 
inhibition gave way to stable enhancement (Fig. 1,   
G and H). Moreover, comparison of I-V plots revealed 
potential, Vm1/2 is the voltage at half-maximal conductance, and 
k is the slope factor.
Immunocytochemistry of CaV subunits
Adult SCG neurons were plated on chamber slides (Nagle Nune 
International), treated with poly-l-lysine, and cultured overnight. 
Cells were washed with PBS twice for 5 min and fixed with 100% 
acetone for 10 min. The fixative was washed away with PBS at 
room temperature three times for 5 min. Cells were then exposed 
to PBS containing 10% normal goat serum for 60 min at room 
temperature followed by incubation with primary antibody for   
60  min  at  room  temperature.  Mouse  anti-CaV2  (NeuroMab), 
rabbit anti-Cav3 (Sigma-Aldrich), and mouse anti-Cav4 (Neuro-
Mab) were diluted 1:1,000 in Antibody Diluent (Dako). There-
after, cells were washed with PBS three times for 5 min and were 
incubated for 60 min in the dark at room temperature with Alexa 
Fluor 488 anti–mouse antibody or Alexa Fluor 488 anti–rabbit an-
tibody (Invitrogen) diluted 1:200 in Antibody Diluent. After incu-
bation  with  secondary  antibodies,  cells  were  washed  with  PBS 
three times for 5 min. A second fixation was performed. Slides 
were then washed with distilled water and covered with the aque-
ous mounting medium Prolong Gold Antifade reagent (Invitro-
gen). Images of immunofluorescence were obtained at room 
temperature using a custom-built, video-rate confocal microscope 
(Sanderson and Parker, 2003) with a 40× objective lens. An excita-
tion wavelength of 488 nm was used, and emission spectra were 
collected with long-pass filters (OGSIS) at 515 nm (Perez and 
Sanderson, 2005).
RT-PCR of CaV subunits
Homogenized  tissue  samples  were  lysed  in  0.8  ml  TRIZOL   
reagent (Invitrogen), and DNA was removed from RNA using 
phenol-chloroform phase separation. Next, RNA was precipitated 
using isopropyl alcohol and washed with 75% ethanol. After dry-
ing, the RNA pellet was dissolved in RNase-free water. Subse-
quently, reverse transcription was performed using 1.0 µl of 10× 
buffer reverse transcriptase, 1.0 µl deoxyribonucleotide triphos-
phate (dNTP) mix (5 mM each of dNTP), 1.0 µl oligo-dT primer 
(0.5 mg/ml), 0.125 µl RNase inhibitor (40 U/µl; Promega), 0.5 µl 
Omniscript Reverse transcription, and RNase-free water to make 
up a total volume of 10 µl (all reagents were obtained from   
QIAGEN unless otherwise noted). The mixture was incubated at 
37°C for 1 h and heated at 93°C for 5 min followed by cooling on 
ice  to  rapidly  inactivate  the  transcriptase.  Aliquots  of  reverse 
transcription  PCR  product  were  amplified  by  PCR  using  the 
primers CaV2a (5-ATAACCACAGAGAGGAGAGCCACA-3 and 
5-TATACATCCCTGTTCCACTCGCCA-3; 258-bp product) and 
CaV3 (5-TCCCTGGACTTCAGAACCAGCAG-3 and 5-TTGT-
GGTCATGCTCCGAGTCCTG-3; 368 bp; Lin et al., 1996). Reac-
tion mixtures for PCR contained 2 µl of template cDNA, 2.5 µl of 
10× buffer, 0.5 µl dNTP mix, and 2 µl each of forward and reverse 
primer and were made up in distilled water to a final volume of 
25 µl. The protocol for amplification was 94°C for 4 min followed 
by 33 cycles of 94°C for 45 s, 60°C for 45 s, 72°C for 1 min, and 
holding at 72°C for 10 min for last extension. PCR products were 
run on 1.8% agarose gel stained with ethidium bromide along 
with a 1,000-bp DNA ladder (Fermentas Life Sciences).
Statistical analysis
Summary data are presented as means ± SEM. A two-tailed paired 
t test was used to determine differences between control and ago-
nist. For comparisons of two different groups, data were analyzed 
by a two-tailed Student’s t test for two means. For multiple com-
parisons, statistical significance was determined using Origin 7.0 
by a one-way ANOVA followed by a Tukey multiple comparison 
posthoc test. Statistical significance was set at P ≤ 0.05.  Heneghan et al. 373
Figure  2.  CaV  determines  N-current  modulation  by  GqPCRs 
and AA. (A–D) HEK-M1 cells were transiently transfected with 
CaV2.2, 2-1, and various CaV subunits. Currents, measured in   
5 mM [Ba
2+], were elicited every 4 s by stepping from 90 to 0 mV 
for 100 ms unless otherwise noted. Representative whole-cell cur-
rent traces were always taken before (black) and 3 min after (red) 
drug application. Averaged normalized I-V plots were taken be-
fore (black closed circles) and 90 s after (red open circles) agonist 
application. n = 3–6 cells per group. For cells expressing CaV2a, 
20 mM [Ba
2+] was used as charge carrier to improve the signal to 
noise ratio. The test potential was adjusted to 10 mV to correct 
for the shift in peak inward current. (E) Histogram summarizing   
N-current modulation after 3 min of 10 µM Oxo-M (gray bars) and 
5 nM SP (black bars). Percent change in current amplitude was 
highly significant between CaV2a and CaV1b, CaV3, or CaV4 
irrespective of whether Oxo-M or SP was applied (**, P < 0.005; 
one-way ANOVA). (F–I) Modulation of N current by 10 µM AA 
shown as current traces and averaged I-V plots (n = 4–5 cells per 
group). (J) Histogram summarizing N-current modulation after   
3 min of AA (**, P < 0.005; one-way ANOVA). Error bars represent 
SEM. Bars, 0.4 nA.
that Oxo-M no longer inhibited current at any potential 
but enhanced current at negative test potentials (Fig. 2 B). 
Although we hypothesized that expression of CaV2a 
would elicit enhancement at negative potentials, sepa-
ration of enhancement from inhibition based on CaV 
expression was unanticipated. Therefore, we tested 
whether other CaVs would dually modulate N current 
by repeating the aforementioned experiments with two 
other neuronal CaVs: CaV1b and CaV4. As with CaV3, 
when either CaV1b (Fig. 2 A) or CaV4 (Fig. 2 D) was 
expressed, Oxo-M inhibited current at all test poten-
tials, indicating that channels containing CaV2a exhibit 
unique N-current modulation by M1Rs.
To determine whether M1Rs uniquely influence the pro-
file of modulation, we examined whether N-current mod-
ulation by another GqPCR depends on CaV. We tested 
NK-1Rs because in SCG neurons, stimulation of M1Rs and 
NK-1Rs inhibits N current through converging signaling 
pathways that require Gq and downstream activation of 
PLC (Shapiro et al., 1994; Kammermeier et al., 2000; Liu 
and Rittenhouse, 2003a). We examined current modula-
tion that occurred after exposure to SP. As with Oxo-M, an 
initial transient inhibition progressed to a stable current 
enhancement  when  CaV2a  was  expressed  along  with 
CaV2.2 and 2-1 (Fig. 3, A and C). In contrast, SP elicited 
sustained inhibition with CaV3 expression (Fig. 2 E and 
Fig. 3, B and C). These data indicate that control of modu-
lation by CaV is a mechanism used by other GqPCRs 
rather than being unique to M1Rs (Fig. 1 A).
AA elicits a profile of N-current modulation similar  
to GqPCR stimulation
AA mimics N-current modulation by M1Rs in SCG neu-
rons and may serve as a downstream messenger of this 
pathway (Liu and Rittenhouse, 2003a). If so, AA also 
should inhibit or enhance recombinant N current simi-
larly to M1R or NK-1R stimulation. When this hypothesis 
was tested, AA’s actions recapitulated the pattern of mod-
ulation  observed  with  M1R  or  NK-1R  stimulation:  en-
hancement  and  inhibition  separated  based  on  CaV 
expression (Fig. 2, F–J). If elevated AA levels mediate en-
hancement and inhibition, both should reverse after 
washout of exogenous AA. As with SCG neurons, washing 
with copious amounts of bath solution or with 1 mg/ml 
BSA reversed modulation (Fig. S2, A–F). Moreover, en-
hancement recurred with a second application of AA   
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Expression of multiple CaV isoforms produces 
heterogeneous N currents
Our findings yield a possible explanation for why SCG 
neurons exhibit both enhancement and inhibition   
of whole-cell N current (Barrett et al., 2001; Liu and 
Rittenhouse, 2003a; Liu et al., 2004). N current’s di-
verse biophysical properties in different neurons have 
been attributed to CaV2.2 coexpression with different 
CaV isoforms within individual neurons (Scott et al., 
1996). Similarly, SCG neurons may exhibit both forms 
of modulation because CaV2.2 coassembles with differ-
ent CaVs. If this hypothesis is correct, the pattern of 
modulation observed in SCG neurons should recapitu-
late in HEK-M1 cells transfected with multiple CaVs. 
When cells were transfected with CaV2a and CaV3, 
the I-V plots recapitulated I-V plots from SCG neurons 
(Liu and Rittenhouse, 2003a), with enhancement oc-
curring at negative potentials and inhibition at posi-
tive potentials after exogenously applied AA (Fig. S3). 
However, unlike activity from SCG neurons (Liu et al., 
2001; Liu and Rittenhouse, 2003a), the currents rap-
idly inactivated. It has been reported that SCG neu-
rons from 4-d-old rat pups express CaV2a, CaV3, and 
CaV4 mRNA with trace amounts of CaV1b mRNA 
(Lin et al., 1996). We verified the presence of CaV2, 
CaV3, and CaV4 protein in freshly dissociated SCG 
neurons by immunocytochemistry (Fig. 4 A). There-
fore,  we  retested  for  the  modulatory  response  in   
HEK-M1 cells transfected with varying ratios of CaV2a-,   
CaV3-, and CaV4-transformed plasmid. Transfection 
with a mixture of cDNAs in the molar ratio of 10:1:1 
for CaV2a/CaV3/CaV4 in a HEK-M1 cell closely re-
capitulated the N-current kinetics we had previously 
observed in SCG neurons (Barrett and Rittenhouse, 
2000; Liu and Rittenhouse, 2003a). Application of 10 µM 
Oxo-M resulted in significant inhibition of currents 
elicited at test potentials 10–50 mV, with no significant 
inhibition at lower potentials (Fig. 4 B). To ensure the 
transfection mixture is an accurate recapitulation of 
the SCG neuron, we harvested fresh SCG neurons 
from neonatal rat pups and tested them using the same 
experimental conditions as we used for the HEK-M1 
cells. We found that application of 10 µM Oxo-M also 
resulted  in  significant  inhibition  of  native  currents 
elicited at test potentials 10–50 mV, with no significant 
change at lower potentials (Fig. 4 C). These findings sug-
gest that the N current observed in SCG neurons re-
sults from heterogeneous expression of different CaV 
isoforms with CaV2.2.
The antibody used in the immunocytochemistry ex-
periments recognizes the peptide sequence RSPKP-
SANSVTSPHSKE (NeuroMab data sheet N8b_1). This 
sequence exists in CaV2a, 2b, 2c, 2d, and 2e but not 2f, 
2g, or 2h. Because the presence of CaV2a variant has 
never been confirmed in rat neonatal SCG neurons, we 
looked for its presence by RT-PCR using primers designed 
corroborate our assertion that AA mediates N-current 
modulation by the slow pathway (Liu and Rittenhouse, 
2003a,b; Liu et al., 2004).
As a final test of AA’s role in the slow pathway, we 
antagonized endogenous AA’s release from membrane 
phospholipids using the PLA2 antagonist OPC. Expo-
sure to Oxo-M for 60 s significantly inhibited N current 
from CaV3-containing channels (P < 0.05; n = 16). In 
contrast, OPC eliminated significant current inhibition 
by Oxo-M (P > 0.05; n = 7; Fig. 1, B, I, and J). A similar 
profile was observed with SP (not depicted). The strik-
ing recapitulation by AA of GqPCR-induced N-current 
enhancement and inhibition, coupled with the loss of 
modulation when antagonizing AA release or sequester-
ing free AA with BSA, advance our previous hypothesis 
that PLA2 and AA participate in the slow pathway (Liu 
and Rittenhouse, 2003a,b; Liu et al., 2004).
Figure 3.  NK-1R stimulation elicits a similar profile of N-current 
modulation as M1Rs. (A and B) HEK-M1 cells were transiently 
transfected with the NK-1R along with CaV2.2, 2-1, and either 
CaV2a (A) or CaV3 (B). Using 5 nM SP as the agonist, current 
modulation is shown in a time course of peak current (left), rep-
resentative whole-cell current traces (middle), and averaged I-V 
plots (right; n = 4). Bars, 0.4 nA. (C) Summary of the modulatory 
effects of SP on currents from cells expressing either CaV2a or 
CaV3 (***, P < 0.005; one-way ANOVA). No significant difference 
in current inhibition was observed from cells expressing CaV3 
with 5 and 250 nM SP (P > 0.26). Error bars represent SEM.  Heneghan et al. 375
in three of three hippocampal samples and in three of 
three SCG samples. We also found CaV3 expression in 
two of three SCG samples but found negligible CaV3 ex-
pression in hippocampal samples.
A model for dual modulation of N current
We established a working model for how CaV2a con-
trols modulation based on previous studies that exam-
ined AA’s mechanism of inhibition of different Ca
2+ 
channels (Barrett et al., 2001; Liu et al., 2001). Our ex-
periments  with  SCG  neurons  demonstrated  that  cur-
rent inhibition by AA occurs intracellularly or within 
the inner leaflet of the membrane. In contrast, enhance-
ment appears located extracellularly or within the outer 
leaflet of the bilayer (Barrett et al., 2001; Liu et al., 
2001).  CaV  subunits  bind  to  cytoplasmic  loops  of 
CaV2.2 (Pragnell et al., 1994). Thus, we hypothesized 
that the unique interactions of CaV2a with CaV2.2 
somehow attenuate inhibition. In SCG neurons (Barrett 
et  al.,  2001;  Liu  et  al.,  2001)  and  with  recombinant 
channels containing either CaV2a or CaV3 (Fig. 5,   
A and B), AA induces initial N-current enhancement, 
which is sustained with CaV2a but for CaV3 is followed 
by a more slowly progressing inhibition. This observa-
tion supports the model. Thus, we postulated that every 
CaV2.2 exhibits current enhancement that becomes 
masked by subsequent, more dominant inhibition.
Because our previous work indicated that enhance-
ment  by  AA  arises  from  increased  voltage  sensitivity 
(Barrett et al., 2001), we compared normalized conduc-
tance–voltage (G-V) curves to determine whether in-
creased  voltage  sensitivity  occurs  independently  of 
CaV2a expression. Both CaV2a- and CaV3-containing 
cells exhibited a negative shift in conductance in re-
sponse to AA (Fig. 5, C and D), demonstrating that AA 
increases N-channel voltage sensitivity independently of 
CaV  subunit  expression.  These  data  suggest  that 
CaV2a’s unique ability to attenuate inhibition reveals 
sustained enhancement. In contrast, inhibition results 
from  increased  stability  of  a  closed  state  (Liu  and   
Rittenhouse, 2000), essentially reducing the number of 
channels available to open. This type of inhibition should 
dominate an increase in voltage sensitivity; if channels 
will not open at any voltage, increasing their voltage 
sensitivity will have little effect on currents. Thus, by 
blocking a dominating inhibition, CaV2a unmasks la-
tent enhancement.
Loss of CaV2a palmitoylation restores partial inhibition  
of N current by Oxo-M or AA
Having established that CaV2a uniquely blocks N-cur-
rent inhibition by GqPCR stimulation or exogenous AA, 
we investigated the structural aspects of CaV2a to de-
termine its mechanism of action. A conspicuous feature 
of CaV2a is its unique palmitoylation of two cysteine 
residues near the N terminus (Chien et al., 1996). Our 
specifically for CaV2a. Using tissue from three different 
animals, we assessed the presence of CaV2a and CaV3 in 
SCG. As a positive control, we used the same three animals 
to run parallel experiments of CaV isoform expression in 
the hippocampus, a region reported to be enriched in 
CaV2 (Day et al., 1998). We found CaV2a expression 
Figure 4.  Expression of multiple CaV subunits in SCG neurons. 
(A, top) Confocal micrographs of individual SCG neurons. Start-
ing from the left, the neurons were exposed to no antibodies, 
secondary antibody (anti–mouse Alexa Fluor 488) only, mouse 
anti-CaV2 followed by secondary rabbit anti–mouse Alexa Fluor 
488,  anti-CaV3  followed  by  anti–rabbit  Alexa  Fluor  488,  and 
mouse anti-CaV2 followed by secondary antibody. (bottom) Cor-
responding view shown in bright field. Bar, 10 µm. (B) Represen-
tative current traces and mean I-V plots taken from HEK-M1 cells 
transiently transfected with a 12:12:10:1:1 ratio of CaV2.2/2-1/ 
CaV2a/CaV3/CaV4; taken before (black) and after (red) 10-µM 
Oxo-M application (n = 6 cells). All currents for the figure were 
recorded using 20 mM Ba
2+. *, P < 0.05; paired t test at each test 
potential.  (C)  Current  traces  and  mean  I-V  plots  taken  from 
freshly dissociated SCG neurons before (black) and after (red) 
application of 10 µM Oxo-M (n = 4 neurons). Error bars repre-
sent SEM. Bars, 0.4 nA. (D) RT-PCR of SCG and hippocampal 
(HC) homogenates from three different 7-d-old rats comparing 
CaV2a and CaV3 expression. RNA from animal #1 generated 
lanes 1, 4, 7, and 10. RNA from animal #2 generated lanes 2, 5, 
8, and 11. RNA from animal #3 generated lanes 3, 6, 9, and 12. 
Lane 13 represents a negative control: RT-PCR reaction without 
isolated RNA.376 Cav2a toggles N-current modulation by GqPCRs
observation that palmitoylated CaV2a interferes with a 
fatty acid–mediated inhibition of CaV2.2 raises the pos-
sibility of direct antagonism between palmitic acid and 
AA (Fig. 5 E). Therefore, we tested a depalmitoylated 
mutant to determine whether CaV2a must be palmi-
toylated to minimize inhibition and reveal enhancement. 
Currents  from  channels  containing  depalmitoylated 
CaV2a (CaV2a[C3,4S]; Chien et al., 1996) exhibited an 
Figure 5.  CaV2a blocks N-current inhibition, revealing latent 
enhancement. (A and B) Time courses of cells expressing either 
CaV2a (A) or CaV3 (B) exposed to AA both exhibit enhance-
ment during the initial phase of time course. However, when 
CaV3  is  present,  inhibition  eventually  dominates,  indicating 
that both inhibitory and enhancement sites are available for AA 
to bind. When CaV2a is present, inhibition no longer occurs, 
suggesting the palmitoylated CaV2a occupies the inhibitory site 
without conferring inhibition. (C and D) Normalized conduc-
tance–voltage plots generated from I-V data show a negative shift 
in G/Gmax for cells expressing either CaV2a (C) or CaV3 (D), 
indicating that an increased sensitivity to voltage is masked by a 
dominating inhibition in cells expressing CaV3. (E) Schematic 
representation of working model. Upon GqPCR stimulation, the 
released AA binds to both inhibitory and enhancement sites on 
the  channel.  When  CaV3  is  present,  both  inhibitory  and  en-
hancement sites are available for AA to bind. However, because 
inhibition dominates, the resultant modulation observed is cur-
rent inhibition. When CaV2a is present, inhibition no longer 
occurs because the palmitoylated CaV2a occupies the inhibitory 
site without conferring inhibition. With inhibition antagonized, 
sustained current enhancement is observed.
Figure 6.  Palmitoylation determines which form of modulation 
is  observed.  (A–F)  Using  20  mM  Ba
2+,  modulation  by  Oxo-M   
or AA of cells expressing mutant CaV2a(C3,4S) (A and B), 
CaV2a1b (C and D), or CaV2a3 (E and F) is shown in current 
traces and I-V plots. Bars, 0.4 nA. (G) Summary of the modulatory 
effects on currents after application of Oxo-M or AA for 3 min   
(n = 4–7). Error bars represent SEM. (H) Schematic representa-
tion of working model.  Heneghan et al. 377
initial transient inhibition after Oxo-M that relaxed, yield-
ing a small but insignificant inhibition (Fig. 6, A and 
G). AA initially enhanced current amplitude, followed 
by significant inhibition (Fig. 6, B and G). The loss of en-
hancement and appearance of inhibition, although dif-
fering in magnitude with Oxo-M or AA, support the idea 
that palmitoylation blocks inhibition.
If palmitoylation is necessary for antagonizing inhibi-
tion, palmitoylating another CaV should convert cur-
rent inhibition to enhancement. Therefore, we tested a 
chimera in which the variable N terminus of CaV1b 
was replaced with the palmitoylated 16–amino acid   
N terminus of CaV2a (CaV2a1b; Chien et al., 1998). 
In cells expressing CaV2a1b, application of Oxo-M 
enhanced current with no inhibition (Fig. 6 G). More-
over, AA no longer inhibited these currents significantly   
(Fig. 6 G) compared with CaV1b (n = 4; Fig. 2 J). The 
difference in modulation by AA and Oxo-M may be   
attributed to an exaggerated response to exogenous   
application of AA compared with the response to physi-
ological concentrations of AA released upon M1R stim-
ulation. I-V plots after either Oxo-M or AA exhibited 
enhancement of current at negative test potentials and 
no inhibition at positive test potentials (Fig. 6, C and D), 
suggesting that the palmitoylated N terminus is both 
necessary and sufficient to block inhibition.
However, a second chimera in which the N terminus 
of CaV3 was replaced with the N terminus of CaV2a 
(CaV2a3; Chien et al., 1998) did not block inhibition 
as effectively. In cells expressing CaV2a3, inhibition by 
Oxo-M was diminished compared with wild-type CaV3, 
whereas AA reversibly inhibited currents similarly to 
wild-type levels (Fig. 6, E–G). I-V plots taken before and 
90 s after application of Oxo-M or AA exhibited inhibi-
tion at positive test potentials (Fig. 6, E and F). These re-
sults  indicate  that  addition  of  CaV2a’s  palmitoylated   
N terminus to CaV3 only partially reproduced the stable 
enhancement by Oxo-M or AA normally observed with 
wild-type CaV2a. Because CaV2a protein shares high-
est sequence homology to CaV1b (Birnbaumer et al., 
1998), the simplest interpretation for the varied results 
with the different chimeras is that that CaV2a1b posi-
tions the palmitoylated N terminus so that it minimizes 
N-current inhibition similarly to wild-type CaV2a. In 
contrast, the more divergent CaV2a3 positions the pal-
mitoylated N terminus in a different position relative to 
CaV2.2 where it is less effective in minimizing inhibition 
(Fig. 6 H). In support of this notion, CaV2a3-con-
taining cells exhibited varied kinetics, from noninacti-
vating currents resembling CaV2a-containing channel 
activity (Fig. 2 B) to rapidly inactivating currents re-
sembling depalmitoylated CaV2a-containing channel 
activity (Fig. 6, A and B). Moreover, the kinetics varied 
within individual recordings and from cell to cell from a 
rapidly inactivating to a noninactivating kinetic profile 
(unpublished data). The unstable inactivation kinetics 
Figure 7.  Palmitic acid antagonizes inhibition of N current by 
GqPCR  stimulation.  HEK-M1  cells  were  transiently  transfected 
with NK-1R, CaV2.2, 2-1, and CaV3. (A) Diagram showing that pre-
incubation of HEK-M1 cells with exogenously applied palmitic acid 
blocks inhibition of N channels by fatty acids, such as AA, released 
after NK-1R or M1R activation. (B) Summary showing preincuba-
tion of cells with 10 µM palmitic acid (PA) significantly attenuates 
inhibition by SP or Oxo-M (*, P < 0.05 compared with percent 
change in the absence of palmitic acid). Error bars represent SEM. 
(C) Modulation of N current by SP from cells expressing CaV3 is 
shown in a representative time course, current traces taken before 
and 3 min after application of SP, and I-V plots (n = 5). (D) Pre-
incubation of cells with palmitic acid causes loss of inhibition by   
SP as shown in a time course, current traces, and I-V plot (n = 6). 
(E) Preincubation of HEK-M1 cells with palmitic acid also causes 
loss of inhibition by Oxo-M, as shown in a representative time 
course, current traces, and I-V plots (n = 4). Bars, 0.4 nA.378 Cav2a toggles N-current modulation by GqPCRs
suggests that CaV2a3 cannot dock properly to CaV2.2, 
thus destabilizing and changing the location of the chi-
mera’s palmitoyl groups.
Free palmitic acid minimizes N-current inhibition
If our interpretation that the palmitoyl groups antago-
nize inhibition is correct, freeing the palmitoyl groups 
from protein constraints might allow the fatty acids to 
find and assume their optimal position for blocking in-
hibition (Fig. 7 A). Alternatively, if the palmitic acids do 
not interact directly with CaV2.2, introducing free pal-
mitic acid should not alter N-channel modulation by 
agonist. We tested this prediction first by preincubating 
cells expressing NK-1Rs and CaV3-containing channels 
with free palmitic acid for at least 8 min. Under these 
conditions, the sustained inhibition normally observed 
with SP (Fig. 7, B and C) was replaced by an initial en-
hancement that relaxed, resulting in no significant 
change (P > 0.24) in current amplitude over time (Fig. 7, 
B and D). Moreover, compared with control conditions, 
little inhibition by SP was detected in I-V plots from cells 
preincubated with 10 µM palmitic acid (Fig. 7, C and D). 
To ensure the block of inhibition was not specific to   
NK-1Rs,  we  tested  N-current  modulation  of  CaV3-
containing channels in HEK-M1 cells by Oxo-M after a 
10-min preincubation with 10 µM palmitic acid. As with 
SP, free palmitic acid prevented the sustained inhibition 
observed in its absence, as demonstrated by time courses 
and I-V plots (compare Fig. 7, B and E with Fig. 1, B–F 
and Fig. 2, C and E). Bath application of palmitic acid for 
8 min did not significantly affect N current (not de-
picted) when compared with currents recorded under 
control conditions (Fig. 7 C), indicating that palmitic 
acid  itself  has  no  modulatory  effect.  These  findings 
demonstrate that exogenous application of free pal-
mitic acid suffices to block current inhibition of CaV3-
containing N channels. More importantly, these results 
indicate palmitic acid is both necessary and sufficient 
to antagonize N-current inhibition during GqPCR stim-
ulation (Fig. 8).
D I S C U S S I O N
In this study, we used a recombinant system to investi-
gate the enhancement and inhibition of N current that 
occurs during M1R stimulation and AA application. In 
so doing, we made the discovery that the N-channel’s 
 subunit directs opposite effects of N-current modula-
tion.  Specifically,  M1R  stimulation  or  exogenous  AA 
uniquely enhanced whole-cell N current from cells ex-
pressing CaV2a but inhibited N current from cells ex-
pressing CaV1b, CaV3, or CaV4. This finding allowed 
us to further examine the modulation of N current and 
reach several additional conclusions. First, the striking 
recapitulation of M1R-induced modulation by AA, cou-
pled with the loss of modulation when AA release by 
OPC is blocked, is strong evidence that AA is an inte-
gral component of the slow pathway. Second, NK-1R 
stimulation exhibited a similar dual effect, indicating 
this unique profile of modulation may be conserved 
among GqPCRs. Third, cells expressing multiple forms 
of CaV subunits matched the modulatory profile of 
SCG neurons under the same recording conditions, 
implying that the characteristic pattern of modulation 
observed in SCG neurons results from CaV2.2 coupling 
with  different  CaV  isoforms.  This  finding  provides   
an explanation of how stimulation of M1Rs or exoge-
nous AA can elicit both enhancement and inhibition 
Figure 8.  Model of interference of inhibition by palmitoylated 
CaV2a. (A) As presented, our data support a model in which 
upon GqPCR stimulation, release of AA initially enhances N cur-
rent by acting at a site distinct from inhibition. However, N-current 
inhibition by AA of channels containing CaV1b, CaV3, or CaV4 
dominates modulation of CaV2.2 and obscures enhancement.   
(B) In the presence of CaV2a, the palmitoylated N terminus of 
the CaV subunit blocks N-current inhibition by endogenously re-
leased AA as a result of the two palmitic acids competitively inter-
acting with CaV2.2, thus revealing latent enhancement.  Heneghan et al. 379
of N current in individual sympathetic neurons (Liu 
and Rittenhouse, 2003a). Fourth, using mutated and chi-
meric CaV  constructs,  we  demonstrated  that  palmi-
toylation of CaV2a is a key feature in its capacity to 
toggle modulation from inhibition to enhancement. 
Finally, exogenous application of palmitic acid pre-
vented  the  characteristic  N-current  modulation  by 
GqPCRs, suggesting that CaV2a’s palmitoyl groups 
interfere with a mechanism or mechanisms within the 
slow pathway.
Increased free AA appears necessary for N-current 
inhibition by the slow pathway
It is well documented that PtdIns(4,5)P2 breakdown by 
PLC is necessary for slow pathway inhibition (Wu et al., 
2002; Liu and Rittenhouse, 2003a; Gamper et al., 2004; 
Liu et al., 2004; Delmas et al., 2005; Suh and Hille, 2005); 
however, whether its breakdown is sufficient for N-cur-
rent inhibition remains controversial (Wu et al., 2002; 
Gamper et al., 2004; Suh and Hille, 2005). Our data in-
dicate that fatty acid liberation is both necessary and suf-
ficient to elicit inhibition of CaV2.2 (Barrett et al., 2001; 
Liu and Rittenhouse, 2003a; Liu et al., 2004, 2007). 
To demonstrate a role for free AA in N-current inhibition, 
we  used  pharmacological  agents,  the  AA  scavenger 
BSA, PLA2 antibodies dialyzed internally, and neurons 
harvested  from  PLA2
/  knockout  mice  (Liu  and   
Rittenhouse, 2003a; Liu et al., 2004, 2006). Here we 
have taken a molecular approach in which expression of 
palmitoylated CaV2a provides a highly specific agent to 
block inhibition by AA, whereas nonpalmitoylated wild-
type CaV subunits conveniently act as negative controls. 
It must be stressed that none of the findings reported 
here  minimizes  PtdIns(4,5)P2’s  role  but  rather  docu-
ments a requirement for AA in N-current inhibition.
A resolution to the paradox would entail a role for 
both PtdIns(4,5)P2 and AA acting either directly or indi-
rectly on the channel. A model for PtdIns(4,5)P2 and AA 
opposing each other in modulation of K
+ channels has 
been published (Oliver et al., 2004) in which PtdIns(4,5)P2 
and AA act at different sites of the channel. Direct com-
petition is possible because AA is an integral piece of the 
PtdIns(4,5)P2 molecule, normally residing in the sn-2 po-
sition, and thus could compete for binding to CaV2.2. Al-
though indirect actions of PtdIns(4,5)P2 and AA must be 
considered, as both are bioactive molecules with multi-
ple downstream effects, no requirement for downstream 
enzymes such as phosphatases or kinases has been found. 
Moreover, antagonizing enzymes that further metabolize 
AA have no effect on modulation (Liu et al., 2001; Liu 
and Rittenhouse, 2003a). Nevertheless, increased levels 
of PtdIns(4,5)P2 increase N-channel availability to open, 
whereas increased levels of AA stabilize N channels in 
closed and/or inactivated states (Liu and Rittenhouse, 
2000; Gamper et al., 2004). These opposing effects sug-
gest competition.
A working model for enhancement and inhibition
By exposing SCG neurons to exogenous AA, we char-
acterized  N-current  enhancement  and  inhibition  as 
distinct molecular events acting at different sites on   
N channels. Restriction of AA movement across the 
cell membrane suggested that enhancement requires 
AA on the extracellular side or within the outer leaflet, 
whereas  inhibition  requires  AA  on  the  intracellular 
side or within the inner leaflet (Barrett et al., 2001). 
These two sites presumably would be equally accessible 
to AA generated internally because movement of long-
chain fatty acids across cell membranes occurs in <1 s 
(Hamilton et al., 2002). Because CaV subunits are cy-
toplasmic, we hypothesized that CaV2a attenuates in-
hibition without affecting enhancement. In dissociated 
neurons, AA induces an initial current enhancement 
followed by a slower progressing inhibition (Barrett   
et al., 2001; Liu et al., 2001). The simplest explanation 
for these data is that the initial enhancement becomes 
masked  by  the  subsequent,  more  dominant,  inhibi-
tion. Because previous work indicated that enhance-
ment stems from increased voltage sensitivity (Barrett 
et al., 2001), we used normalized G-V curves (Fig. 5) to 
show that an increase in voltage sensitivity occurs inde-
pendently of CaV2a expression. In contrast, inhibi-
tion  results  from  an  increase  in  a  slow  form  of 
inactivation most likely as a result of increased dwell 
time in one or more intermediate closed states (Liu 
and Rittenhouse, 2000). This type of inhibition would 
essentially reduce the available number of channels 
providing  calcium  influx,  dominating  an  enhance-
ment produced by a shift in voltage sensitivity. Thus, 
by blocking a dominant inhibition, CaV2a unmasks a 
latent  enhancement.  The  masking  of  enhancement   
offers some explanation for the finding that the major-
ity of studies on N-current modulation have observed 
inhibition (Elmslie, 2003).
Nevertheless,  enhancement  and  inhibition  have 
been reported from experimental systems similar to 
the one used here. For example, AA both shifts activa-
tion toward negative potentials and simultaneously in-
creases steady-state inactivation of T channels (Talavera 
et al., 2004). Also, in SCG neurons, the amide of AA, 
anandamide, elicited enhancement at negative poten-
tials and inhibition at positive potentials in I-V plots 
(Guo  and  Ikeda,  2004).  Enhancement  marked  by  a 
leftward  shift  in  voltage  sensitivity  was  reported  for   
R-type channels in the hippocampus (Tai et al., 2006), 
a  region  in  which  CaV2  is  highly  expressed  (Day   
et al., 1998). Finally, using HEK-293 cells transiently 
transfected with recombinant M1Rs and N channels 
containing CaV3, an earlier study showed that car-
bachol  inhibited  Ca
2+  current  with  no  obvious  en-
hancement (Melliti et al., 2001). However, I-V curves 
showed a discernible leftward shift in voltage sensitivity   
after carbachol.380 Cav2a toggles N-current modulation by GqPCRs
A new role for palmitoyl groups of palmitoylated proteins
Our  data  identify  a  previously  unrecognized  role  for 
protein palmitoylation in which it serves as the key fea-
ture of CaV2a’s capacity to toggle CaV2.2 modulation 
from  inhibition  to  enhancement  after  stimulation  of 
GqPCRs. Here and in other systems, palmitoylation tar-
gets or anchors proteins to specific membrane domains 
(Chien et al., 1996; Resh, 2006). Although dynamic pal-
mitoylation of CaV2a has been shown to alter the inac-
tivation kinetics of voltage-gated Ca
2+ channels in bovine 
chromaffin cells, the assumed mechanism of action is 
restriction of movement of channel domains by anchor-
ing the CaV2a subunit to the membrane (Hurley et al., 
2000). This anchoring in some way is thought to impede 
current inactivation (Restituito et al., 2001). Thus, pal-
mitoylation increases protein stability and efficiency of 
action but rarely alters the functional properties of pro-
teins. One exception to this generalization is retinal epi-
thelial protein 65 (RPE65), a chaperone protein for 
all-trans-retinal esters. In this case, palmitoylation not 
only targets RPE65 to the plasma membrane but also re-
verses RPE65’s binding specificity for vitamin A to all-
trans-retinyl  ester,  consequently  affecting  how  rapidly 
photoreceptors respond to light (Xue et al., 2004). Thus, 
palmitoylation qualitatively alters the substrate specific-
ity of the same protein that is reversibly palmitoylated. 
Here, our data extend the functions of palmitoylation in 
a new direction by revealing that after stimulation of 
GqPCRs, the palmitoyl groups of one protein, CaV2a, 
block inhibition of a second protein, CaV2.2.
Our finding that palmitoylation antagonizes an inhi-
bition  mediated  by  PtdIns(4,5)P2  breakdown  and  in-
creased free AA (Liu and Rittenhouse, 2003a; Gamper 
et al., 2004) raises the possibility that dual palmitoyl 
groups interact directly with CaV2.2 to antagonize AA’s 
interaction with CaV2.2 and subsequent inhibition of 
N-channel activity. The idea that AA may interact directly 
with Ca
2+ channels is supported by the finding that M1R 
stimulation or application of exogenous AA also inhib-
its recombinant CaV3 currents in whole-cell (Zhang   
et al., 2000; Talavera et al., 2004; Hildebrand et al., 2007) 
and ripped-off patch configurations (Chemin et al., 
2007). Because CaV3 (T type) channels do not require 
coexpression of CaV or 2 to open, T-channel inhibi-
tion must occur at a site on the pore-forming subunit. 
Moreover, AA inhibits T current with a Hill coefficient 
of 1.6, indicating cooperative binding of at least two 
AA  molecules  to  T  channels  (Talavera  et  al.,  2004). 
Collectively, these findings are consistent with a direct 
interaction between AA and T channels. AA likely con-
fers N-current inhibition by acting at a homologous 
site found on many CaV channels because native and 
recombinant CaV1, CaV2, and CaV 3 channels exhibit 
similar  changes  in  gating  after  AA  (Shimada  and   
Somlyo, 1992; Petit-Jacques and Hartzell, 1996; Liu and 
Rittenhouse, 2000; Vellani et al., 2000; Talavera et al., 
2004; Chemin et al., 2007; Liu, 2007; Roberts-Crowley 
and Rittenhouse, 2009).
Palmitoylated CaV2a may serve as a phospholipid  
mimic by competing with PtdIns(4,5)P2 and free AA  
for interaction with CaV2.2
Under basal conditions, AA normally resides in the sn-2 
position of PtdIns(4,5)P2. Because palmitoylated CaV2a 
appears to antagonize the actions of free AA on CaV2.2, 
it may also compete with PtdIns(4,5)P2 for interaction 
with CaV2.2, the two palmitic acids of CaV2a residing in 
sites normally occupied by the two fatty acid tails of 
PtdIns(4,5)P2. Consistent with its ability to block N-cur-
rent inhibition by free AA, palmitoylated CaV2a acts as 
a phospholipid mimic to maintain normal channel ac-
tivity (Fig. 8). This model is attractive in that it incorpo-
rates previous models, which propose that PtdIns(4,5)P2 
associates with channels, increasing their availability to 
open (Wu et al., 2002; Gamper et al., 2004). The model 
also  supports  our  previous  findings  (Liu  and  Ritten-
house, 2003a) that increased free AA confers current 
inhibition either by displacing PtdIns(4,5)P2 or by re-
maining associated with channels after phospholipid 
breakdown (Roberts-Crowley et al., 2009).
Our findings that free palmitic acid blocks inhibition 
by SP of CaV3-containing channels or depalmitoylated 
CaV2a-containing channels (see Mitra-Ganguli et al. in 
this issue) is consistent with the idea that the palmitic 
acids occupy the same sites recognized by AA. Whether 
PtdIns(4,5)P2 as well as AA compete for the same site of 
interaction  with  CaV2.2  as  the  palmitoyl  groups  of 
CaV2a and where the location of that site is awaits fu-
ture  investigation.  However,  we  have  observed  that 
whole-cell recombinant current from CaV2a-contain-
ing channels, in contrast to CaV3-containing channels 
(Gamper et al., 2004), run down only minimally over 
time (unpublished data), consistent with palmitoylated 
CaV2a functionally substituting for PtdIns(4,5)P2. Thus, 
when taken together, our findings and the results of 
other  laboratories  best  fit  a  model  in  which  palmi-
toylated CaV2a, PtdIns(4,5)P2, and free AA compete 
for an overlapping interaction site on CaV2.2. Given the 
extent that lipids such as PtdIns(4,5)P2 and AA associ-
ate with membrane protein complexes (Piomelli, 1993; 
Doughman et al., 2003), the interference of such inter-
actions by palmitoylated proteins is predicted to occur 
in other protein complexes, yielding broad importance 
beyond ion channel functioning.
Expression of palmitoylated CaV2a may underlie novel 
forms of synaptic plasticity
In particular, the presence or absence of palmitoylated 
CaV2a may have far-reaching consequences for synap-
tic plasticity. CaV2 expression displays an overlapping 
distribution  with  GqPCRs  (Tencé  et  al.,  1994;  Liu   
and Rittenhouse, 2003a) throughout the brain and is   Heneghan et al. 381
primarily localized postsynaptically in dendrites and 
cell bodies (Lie et al., 1999), indicating that enhance-
ment of Ca
2+ channel activity may specifically affect 
postsynaptic membrane excitability. In support of this 
notion, increased current amplitude and/or kinetic 
changes  associated  with  Ca
2+  current  enhancement 
(Zhang et al., 2000; Bannister et al., 2004; Guo and 
Ikeda,  2004;  Talavera  et  al.,  2004;  Tai  et  al.,  2006;   
Chemin et al., 2007; Mitra-Ganguli et al., 2009) occur 
in different neurons and recombinant channels from 
the CaV2 and CaV3 families (Keyser and Alger, 1990; 
Melliti et al., 2001; Chemin et al., 2007; Meza et al., 
2007). In contrast, native or recombinant channels as-
sociated with CaV1b, CaV3, or CaV4 exhibit inhibi-
tion after similar stimulation (Keyser and Alger, 1990; 
Liu and Rittenhouse, 2003a; Gamper et al., 2004; Guo 
and Ikeda, 2004; Meza et al., 2007). Because CaV2 ex-
pression changes developmentally (Tanaka et al., 1995) 
and with activity (Lie et al., 1999), postsynaptic re-
sponses also may change over time. Patients with tem-
poral  lobe  epilepsy  exhibit  increased  postsynaptic 
CaV2 expression in damaged hippocampal regions. 
In contrast, patients that underwent surgical lesioning 
exhibit  hippocampal  CaV  levels  indistinguishable 
from control patients (Lie et al., 1999), suggesting 
CaV2 expression is dynamically regulated by electri-
cal activity. Moreover, it has been reported that al-
though CaV expression appears necessary for surface 
expression of the N channel, once the channel reaches 
the cell surface, the CaV subunit can be exchanged 
(Restituito et al., 2001; Hidalgo et al., 2006). Thus, 
changes in current modulation caused by changes in 
CaV expression should not require a turnover of the 
entire channel complex.
Whether up-regulation of CaV2 is a response to 
counteract hyperexcitability or whether increased CaV2 
levels contribute to excitotoxic neurodegeneration has 
not been determined. Nevertheless, these findings doc-
ument in vivo plasticity of CaV2 expression. In the 
short term, palmitoyl acyl transferases dynamically reg-
ulate protein palmitoylation in hippocampal dendrites 
and cell bodies to control synaptic function (El-Husseini 
et al., 2002; Fukata et al., 2004). Pulse–chase experi-
ments using tritiated palmitate indicate that palmitate 
turns over multiple times during the lifetime of most 
palmitoylated proteins, and recent experiments suggest 
that the pulse–chase experiments may underestimate 
the turnover rate by 15–20-fold as a result of reacylation 
of proteins by the radiolabeled palmitate within a cell 
(for review see Baekkeskov and Kanaani, 2009). Thus, 
expression  of  CaV2a  in  postsynaptic  regions  should 
create a previously unrealized level of plasticity in which 
the response to a transmitter, acting on its GqPCR from 
moment to moment, may switch from inhibitory to exci-
tatory depending on whether CaV2a’s palmitoyl groups 
interact with CaV2.2.
A role for multiple CaV isoforms in neurons
In summary, we have shown that multiple CaV isoforms 
expressed in a recombinant system can recapitulate na-
tive N-current modulation by the slow pathway. Given 
the diversity of neuronal functions for calcium influx, 
there must be localized control of a channel’s response 
to modulation. Our findings provide a previously unrec-
ognized role for CaV subunits in the control of modula-
tion and indicate a means by which GqPCR stimulation 
can simultaneously up- and down-regulate calcium flux 
at distinct sites within a single cell. Moreover, our experi-
ments and analyses identify the sites that confer sensitiv-
ity to inhibition by AA as a likely site of plasticity.
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